In the BioHarmony Drug Report Database

"Preview" Icon

Almotriptan

Axert (almotriptan) is a small molecule pharmaceutical. Almotriptan was first approved as Axert on 2001-05-07. It is used to treat migraine disorders in the USA. It is known to target 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D.

 

Trade Name

 

Axert
 

Common Name

 

almotriptan
 

ChEMBL ID

 

CHEMBL1505
 

Indication

 

migraine disorders
 

Drug Class

 

Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives

Image (chem structure or protein)

Almotriptan structure rendering